MedPath

Increase endometrial thickness with autologous conditioned serum

Phase 1
Recruiting
Conditions
Infertility due to low endometrial thickness.
Endometriosis
Registration Number
IRCT20160422027520N15
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
10
Inclusion Criteria

Women between the ages of 25-40 years
Failed in vitro fertilization (IVF)
The availability of individual during the study period
Having a history of infertility
Endometrial thickness less than 7 mm

Exclusion Criteria

Having a financial incentive to participate in the study or Participate in another study simultaneously
Endometrial thickness more than 7 mm
People with malignancy
Previous delivery with cesarean section or having a normal pregnancy history
Having a history of curettage
Having pelvic inflammatory disease (PID)
History of radiotherapy at an in the past
People with Asherman's Disease

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of autologous conditioned serum on endometrial thickness. Timepoint: 1 and 4 weeks after autologous conditioned serum injection. Method of measurement: Using sonography.
Secondary Outcome Measures
NameTimeMethod
The effect of processed autologous serum on fertility rate of patients. Timepoint: 1, 4 and 12 weeks after in vitro fertilization (IVF). Method of measurement: Using sonography and Serum beta-human chorionic gonadotropin (ß-hCG) level assessment by enzyme-linked immunosorbent assay (ELISA) kit.
© Copyright 2025. All Rights Reserved by MedPath